Point-of-Care Immunoassay for Detection of Bacterial Sinusitis

  • End date
    Mar 10, 2023
  • participants needed
  • sponsor
    ENTvantage Dx
Updated on 10 December 2021


This study is conducted to evaluate the performance of a rapid, point-of-care in vitro diagnostic device (Sinu-Test) for the qualitative detection of the three most common pathogens responsible for causing bacterial sinusitis.


Mucous specimens will be collected from patients displaying symptoms of acute bacterial sinusitis enrolled by primary care and/or otolaryngology clinics in the United States. Health care professionals not having endoscopy certification will collect specimens using the Entvantage sample collection device. Health care professionals with nasal endoscopy certification or specialty training will collect comparator specimens using an endoscope. Untrained operators with a range of education and training (primary care physician, otolaryngologist, physician assistant, nurse practitioner, registered nurse or other healthcare professional), will perform the Sinu-Test lateral flow assay in an outpatient setting. Mucous samples will be tested for the presence of 3 bacterial pathogens responsible for sinusitis using the Sinu-Test in the clinic and by a composite comparator method comprised of standard quantitative bacterial culture with identification (matrix-assisted laser desorption/ionization-Time of Flight (MALDI-TOF) mass spectrometry instrument) and semiquantitative real-time polymerase chain reaction (real-time PCR) of the residual culture sample and the Sinu-Test residual swab performed by a central laboratory.

Condition Sinusitis Bacterial, bacterial sinusitis
Treatment rapid in vitro diagnostic test, bacterial culture, PCR assay
Clinical Study IdentifierNCT03584737
SponsorENTvantage Dx
Last Modified on10 December 2021


Yes No Not Sure

Inclusion Criteria

Meets definition of acute sinusitis by Infectious Disease Society of America (2012)

Exclusion Criteria

Chronic sinusitis
Cystic fibrosis
Patients treated with antibiotics currently or within the previous 30 days
Subjects with a prior history of sinus surgery will be excluded due to the modification of sinonasal anatomy
Primary immunodeficiencies, as self-reported
Combined variable immunodeficiency
Immunodeficiency with reduced immunoglobulin G (IgG) and immunoglobulin A (IgA)-bearing cells
Kartagener Syndrome (ciliary dyskinesia)
Sickle cell disease
Acquired immunodeficiencies, as self-reported
Radiation therapy
Poorly controlled Diabetes mellitus
Cognitive impairment resulting in the inability to provide informed consent
Special groups, such as children under the age of 18, and men and women who are in prison will not participate in this study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note